Kwality Pharmaceuticals Ltd — Important, 06-11-2025: Company Update

Kwality Pharmaceuticals successfully completed its EU-GMP audit for the General and Beta-Lactam units at its Amritsar facilities, with no major observations. This achievement highlights the company's commitment to global quality standards. With these additions, Kwality Pharma now boasts four EU-approved facilities, including Cephalosporin and Oncology units. This strengthens its standing as a trusted global pharmaceutical manufacturer, paving the way for expanded presence in regulated international markets and fostering new growth and collaboration opportunities.